Surgical Science Sweden AB

Chart & performance

D1W1MN

P/E

40.78

P/S

2.75

EPS

1.31

Div yield, %

—

Shrs. gr., 5y

8.22%

Rev. gr., 5y

56.77%

Revenues

992m

+12.25%

Net income

67m

-49.24%

CFO

80m

-41.85%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, for procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecology, hysterectomy, bariatrics, and nephrectomy; EndoSim, for endoscopy simulation; and TeamSim, for realistic training of collaboration within a surgery team. The company was founded by Anders Hyltander, David Löfstrand, and Anders Larsson on July 24, 1997 and is headquartered in Gothenburg, Sweden.

Related entities

Subsidiaries

INTELLIGENT ULTRASOUND GROUP PLC

URL

https://surgicalscience.com/

IPO date

Jun 19, 2017

Employees

259

Domiciled in

Incorporated in

Headquarters & legal address

Drakegatan 7A, 3 vån
Göteborg, O 412 50
SE

Address

Drakegatan 7A, 3 van
Goteborg, O 412 50
SE

Valuation

Order:

Title SEK in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title SEK in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT